Phase III trial evaluating sotorasib + panitumumab: MCC patients with rare tumor mutation experienced superior PFS compared to standard of care

Advancing quality of life in oncology: A journey of compassion and innovation

The recent ASCO guideline update on palliative care for cancer patients represents a significant milestone in our field’s evolution. This evidence-based guidance emphasizes what I’ve advocated throughout my career—that palliative care must be integrated early and concurrently throughout the cancer journey. This holistic approach to cancer care has been my life’s work and passion.

Sotorasib + panitumumab offers better outcomes in colorectal cancer that no longer responds to treatment

A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped responding to chemotherapy, according to a phase III clinical trial by researchers at City of Hope.

May 02, 2025

Vol.51 No.17

Advancing peritoneal oncology: Innovations in surgical strategies and research

Peritoneal metastases arise from gastrointestinal and gynecologic malignancies, leading to debilitating symptoms and poor prognoses. They remain one of the most challenging manifestations of advanced malignancies, often leading to significant morbidity and limited treatment options.

Regulation must keep up with scientific advances

The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.

April 25, 2025

Vol.51 No.16

By Richard M. Goldberg

City of Hope’s BMT program performs 20,000th transplant
49-year history creates 20,000 tomorrows

This year marks the 49th anniversary of the City of Hope bone marrow transplant program, which was conceived and developed by Ernest Beutler and Karl Blume in 1975, with help and inspiration from E. Donnall Thomas, the 1990 Nobel Laureate in Physiology and Medicine.

Hope Rugo named director of City of Hope’s Women’s Cancers Program

Hope S. Rugo has joined City of Hope to lead its Women’s Cancers Program throughout the organization and breast medical oncology division section.

April 18, 2025

Vol.51 No.15

Phase III trial evaluating sotorasib + panitumumab: MCC patients with rare tumor mutation experienced superior PFS compared to standard of care

YOU MAY BE INTERESTED IN

Advancing quality of life in oncology: A journey of compassion and innovation

Sotorasib + panitumumab offers better outcomes in colorectal cancer that no longer responds to treatment

Advancing peritoneal oncology: Innovations in surgical strategies and research

Regulation must keep up with scientific advances

City of Hope’s BMT program performs 20,000th transplant
49-year history creates 20,000 tomorrows

Hope Rugo named director of City of Hope’s Women’s Cancers Program

Renew today!

Subscriber content

Never miss an issue!

Login

Phase III trial evaluating sotorasib + panitumumab: MCC patients with rare tumor mutation experienced superior PFS compared to standard of care

YOU MAY BE INTERESTED IN

Advancing quality of life in oncology: A journey of compassion and innovation

Sotorasib + panitumumab offers better outcomes in colorectal cancer that no longer responds to treatment

Advancing peritoneal oncology: Innovations in surgical strategies and research

Regulation must keep up with scientific advances

City of Hope’s BMT program performs 20,000th transplant49-year history creates 20,000 tomorrows

Hope Rugo named director of City of Hope’s Women’s Cancers Program

Never miss an issue!

Login

City of Hope’s BMT program performs 20,000th transplant
49-year history creates 20,000 tomorrows